KanceRx

Patients we treat are not the ones we study,Patients we study are not the ones we treat.

Digitalize Personalized Medicine 

KanceRx

1.Patients we study are not the Patients we treat and Patients we treat are not the ones we study.

2.The Modern Day Country Doc-“The Concierge Project”

3.Better quality and quantity of life for cancer patients

Patients we study are not the ones we treat,and,Patients we treat are not the ones we study.

Modern day  application of “The ART of Medicine” to engage real lives of patients

Digitize and democratize Realword,Realtime,Real life data of ALL cancer survivors using existing technology to both elicit and solicit information with 24-7 connectivity

1.Continue to expand the “Modern Day Country Doc” model

2.Develop the technology platform to bring together “Connectivity-CarePlan-Insights”

3.Expend the current “Proof of Concept” to a scalable “Business model”

Current data base of about 750 cancer patients to expand to 1500 in 2-3 years and exponentially to 5000+ Cancer patients in 5years

Total addressable market - Immediate access is 1000 Cancer Survivors

Total addressable market - short term (@5years)is 5000

Total addressable market in the US for example is 500,000 Prostate Cancer survivors out of 3.4 million total Prostate Cancer survivors.

Our solution will allow relationship with healthcare professionals who care for these patients.Patients and communities will access through their physicians .

I‘ve just uploaded a movie to YouTube!
You can check it out here:

750 Cancer Patients since 8/1/2016

I‘ve just uploaded a movie to YouTube!
You can check it out here:

1000 Cancer patients in the next 12-24 months

Expect more patients-up to and above 5000 in 5 years.

Improved Quality of life,Quantity of life and access to AI based “Digitalized-Personalized”care

Relationships

Clinical and Business expertise in Cancer Care

Revenue related to “After market Clinical and Bio-Psycho-social insights” with applicable lines of revenues from the de-identified Data,where cancer survivors own their data and are aligned in the downstream economics .

supports Innovation

Financing

Start up costs of the “Technology”platform